This article explains how FDA Class I, II and III medical devices differ by risk, regulatory controls, premarket pathways and compliance planning. It also notes common classification errors…
CE medical device marking is not just a logo exercise. It depends on the right product qualification, MDR classification, documented evidence, and, for many devices, notified body review.
Regulated products in healthcare need the right classification before teams plan market access, labeling, quality controls, advertising, and postmarket duties. This guide explains key FDA and EU concepts…
FDA classification is more than a label. It sets the level of regulatory control and often points to the likely premarket route, from 510(k) exemption to 510(k), De…
EN ISO 13485 is the European adoption of ISO 13485:2016 for medical device quality management systems. This article explains how it differs from ISO 13485, why A11:2021 matters,…
FDA medical device classification determines the regulatory controls that apply before and after a device enters the U.S. market. This article explains the differences between Class I, II…
ISO 13485 is central to medical device QMS planning, especially after FDA QMSR took effect in 2026. This article explains core controls, U.S. and EU links, and audit-ready…
MDR classes divide EU medical devices into Classes I, IIa, IIb and III according to intended purpose and inherent risk. This guide explains how Annex VIII rules work,…
CE approval for medical devices is often used as shorthand for CE marking. Under the EU MDR, the route depends on device classification, clinical evidence, notified body involvement…
Being under regulation in healthcare depends on intended use, risk, data handling and market claims. This article explains how to assess obligations before launch.
